Health Condition 1: L209- Atopic dermatitis, unspecified
Conditions
Interventions
Intervention1: Nerium Oleander: Selection Of Potency Will Be Based On Totality Of Symptoms And Susceptibility Of Patient And The Case Will Be Reviewed Every 7 And 15 Days Depending Upon The Requiremen
Sponsors
Dr Sonal Yogendra Tiwari
Eligibility
Inclusion criteria
Inclusion criteria: i.Patients diagnosed with Atopic Dermatitis as per Hanifin and Rajka criteria and serum IgE levels. ii.Patients of age groups from 18 to 60 years. iii.Patient whose SCORAD index would be mild to moderate in terms of severity. iv.Patients who have not taken any antihistamines or corticosteroids for at least 7 days prior to the start of treatment. v.Patients willing to give informed consent and comply with the study protocol.
Exclusion criteria
Exclusion criteria: i.Patients with suffering from secondary infection like presence of infected eczema, impetigo, eczema herpeticum, or other acute bacterial and viral skin infections. ii.Patients with age less than 18 years and more than 60 years. iii.Patients with severe SCORAD scored disease should not be considered. iv.Patients who have taken any antihistamine or corticosteroid for at least 7 days prior to treatment with homoeopathic medicine. v.Patients with other dermatological conditions co-existing chronic skin diseases like psoriasis, seborrheic dermatitis, contact dermatitis, etc., that may interfere with diagnosis or outcome. vi.Patients with immunocompromised status, autoimmune diseases, or systemic infections. vii.Pregnant or lactating women ,unless ethically approved and monitored. viii.Patients who are unable or unwilling to comply with the study protocol, such as adhering to treatment regimen and attending follow-up visits
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mean change in SCORAD Index (Scoring Atopic Dermatitis Index) score from baseline to end of treatment.Timepoint: 00-03 months for enrollment of cases | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in Visual Analogue Scale VAS for pruritus and sleep loss. Timepoint: 3rd , 6th , 9th months;Proportion of participants achieving equal to or more than 50 percentage reduction in SCORAD index scoreTimepoint: 3rd,6th,9th month | — |
Countries
India
Contacts
Public ContactDr Bankim A Patel
Anand Homoeopathic Medical College And Research Institute,Anand
Outcome results
None listed